Affluent Medical: Status of shares and voting rights as of February 28, 2025

Affluent Medical, a company listed on Euronext Paris, has announced details of its share capital and voting rights as of February 28, 2025. The share capital consists of 39,348,185 shares. The company declares 55,576,930 theoretical voting rights, which include non-voting shares. The exercisable voting rights total 55,407,121, in accordance with the recommendations of the AMF. This communication aims to inform the public in accordance with the legislation in force.

Based in Aix-en-Provence, Affluent Medical develops innovative medical implants. Its short-term objectives include strategic financing and clinical studies for potential commercialization of its products in 2026.